SOP

Luminar Achieves Critical Production Milestone for Volvo Cars Program

Retrieved on: 
Friday, October 6, 2023
Technology, Automotive, General Automotive, Vehicle Technology, Automotive Manufacturing, Manufacturing, Software, Hardware, Artificial Intelligence, Lidar, Luminar Technologies, SOP, Car, Supply, Volvo, Rate, EVP, Automotive industry

The company successfully passed its first major Run at Rate production test for Volvo Cars at its highly automated, high volume manufacturing facility in Monterrey, Mexico.

Key Points: 
  • The company successfully passed its first major Run at Rate production test for Volvo Cars at its highly automated, high volume manufacturing facility in Monterrey, Mexico.
  • The successful completion of the test for Volvo Cars demonstrates Luminar's ability to achieve scale and underscores the company’s commitment to the highest standards of automotive safety.
  • “Passing Volvo Cars’ Run at Rate is a key inflection point for Luminar to drive broad scale adoption of our technology,” said Kevin Hinge, EVP of Supply Chain and Manufacturing.
  • Luminar has demonstrated clear commitment and results by passing our Run at Rate milestone on the path to taking the technology to customers across the globe.”
    Earlier this month, the Volvo team also completed the first installation of Luminar’s high performance LiDAR onto a Volvo EX90 manufactured at their Charleston plant, marking yet another critical milestone for Luminar in the path to start of production for Volvo Cars.

Decisions to Unveil Cutting-Edge AI Solutions at Booth #132 at the 2023 Gartner IT Symposium/Xpo

Retrieved on: 
Wednesday, October 11, 2023
Entrepreneurship, Organization, RFP, SOP, Gartner, Automation, Sales, Customer service

VIRGINIA BEACH, Va., Oct. 11, 2023 /PRNewswire/ -- Decisions is pleased to announce its participation in the 2023 Gartner IT Symposium/Xpo, where the company is set to unveil its latest AI integration solutions, introducing a new dimension to its no-code process automation platform.

Key Points: 
  • VIRGINIA BEACH, Va., Oct. 11, 2023 /PRNewswire/ -- Decisions is pleased to announce its participation in the 2023 Gartner IT Symposium/Xpo, where the company is set to unveil its latest AI integration solutions, introducing a new dimension to its no-code process automation platform.
  • Decisions excels in streamlining processes, reducing manual efforts, and expediting business operations through its robust rules engine and workflow management capabilities.
  • Visitors to the Decisions booth will have the opportunity to explore real-world use cases, addressing common challenges prevalent in the IT landscape.
  • To learn more about Decisions and its participation at the Gartner IT Symposium, attendees are encouraged to visit Booth #132 during the event or explore the company's website.

NEWITY Now Helps Small Businesses to Access Larger SBA 7(a) Loans with Fewer Requirements

Retrieved on: 
Wednesday, October 4, 2023
SBA, SOP, Entrepreneurship, Small business, Growth, Real estate, Bank

CHICAGO, Oct. 4, 2023 /PRNewswire/ -- Today, NEWITY, America's source for small business capital, announces access to larger business loans through the U.S. Small Business Administration's (SBA) update to their Standard Operating Procedures (SOP). NEWITY is proud to simplify and streamline access to small business financing for entrepreneurs through an SBA-licensed lender.

Key Points: 
  • CHICAGO, Oct. 4, 2023 /PRNewswire/ -- Today, NEWITY , America's source for small business capital, announces access to larger business loans through the U.S. Small Business Administration's (SBA) update to their Standard Operating Procedures (SOP).
  • NEWITY is proud to simplify and streamline access to small business financing for entrepreneurs through an SBA-licensed lender.
  • The SBA's SOP updates enable lenders to approve larger loans for businesses who meet lower qualification standards, helping more small business owners access capital.
  • Luke LaHaie, Co-Founder and Co-CEO of NEWITY added, "We're thrilled to offer business owners access to larger loans.

Cultivating Entrepreneurial Talent on the Global Stage: Shangtong Food Takes Taiwanese Bubble Tea Worldwide

Retrieved on: 
Wednesday, September 27, 2023
Food, Drink, Internet, Original equipment manufacturer, Research, SOP, Milk, Student, Entrepreneurship, Dream, OEM, Tea

This model aims to replicate Taiwan's chain brand operation methods worldwide, thus promoting and expanding local Taiwanese brands to have a global impact.

Key Points: 
  • This model aims to replicate Taiwan's chain brand operation methods worldwide, thus promoting and expanding local Taiwanese brands to have a global impact.
  • Shang Tong Food has been involved in the global bubble tea market for over 40 years, marketing its products in more than 60 countries.
  • To further penetrate the global markets, Shang Tong Food offers assistance to entrepreneurs seeking to start businesses abroad.
  • This approach ensures that beverages like bubble tea can elevate local Taiwanese brands and have a significant international influence.

RedSail Technologies and LSPedia Announce Full Platform Integration with OneScan Pharmacy Pro - A Seamless Fusion of Pharmacy Management and DSCSA Compliance at Special Pricing

Retrieved on: 
Tuesday, September 26, 2023
Regulatory compliance, EPCIS, Partnership, Pharmacy, Food, NABP, ASN, Drug Quality and Security Act, SOP, Procrastination, DSCSA, Pinnacle, Health, FDA, Dark Enlightenment, Medical device

For that reason, we've selected LSPedia, who has proven to be the industry's DSCSA leader in quality, performance, and expertise.

Key Points: 
  • For that reason, we've selected LSPedia, who has proven to be the industry's DSCSA leader in quality, performance, and expertise.
  • We have earned and continue to earn trust from pharmacies, and integrating OneScan Pharmacy Pro upholds and improves on that standard."
  • On the flip side, RedSail pharmacies using NRx or PrimeCare can also leverage OneScan Pharmacy Pro to meet their DSCSA solution needs, without direct software integration.
  • With OneScan Pharmacy Pro's integration in PioneerRx, pharmacies are equipped with a tried-and-tested, robust mechanism to navigate DSCSA compliance.

Clario teams up with CellCarta to transform clinical trial sample management for histopathology studies

Retrieved on: 
Tuesday, September 26, 2023
CT, Partnership, Gastroenterology, NASH, Clinical trial, Pathology, PET, CFR, Crohn's disease, MRI, SOP, UC, Title 21 CFR Part 11, Quality control, Biopsy, Software, Medical imaging, Clario Tech

PHILADELPHIA, Sept. 26, 2023 /PRNewswire/ -- Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, proudly announces a strategic partnership with CellCarta, experts in integrated sample management and specialized laboratory services. Together, Clario and CellCarta are set to make significant strides in improving clinical trial sample handling, ensuring seamless operations and unprecedented access within Clario's innovative platform.

Key Points: 
  • Clario and CellCarta's strategic partnership enhances clinical trial sample handling and digitization within Clario's web-based 21 CFR Part 11 compliant platform.
  • Together, Clario and CellCarta are set to make significant strides in improving clinical trial sample handling, ensuring seamless operations and unprecedented access within Clario's innovative platform.
  • CellCarta's clinical trial sample management offers kit provisioning and sample accessioning, processing, digitization, and quality control.
  • To explore the future of clinical trial sample management and learn more about Clario's transformative healthcare research technology, visit Clario.com .

Clario teams up with CellCarta to transform clinical trial sample management for histopathology studies

Retrieved on: 
Tuesday, September 26, 2023
CT, Partnership, Gastroenterology, NASH, Clinical trial, Pathology, PET, CFR, Crohn's disease, MRI, SOP, UC, Title 21 CFR Part 11, Quality control, Biopsy, Software, Medical imaging, Clario Tech

PHILADELPHIA, Sept. 26, 2023 /PRNewswire/ -- Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, proudly announces a strategic partnership with CellCarta, experts in integrated sample management and specialized laboratory services. Together, Clario and CellCarta are set to make significant strides in improving clinical trial sample handling, ensuring seamless operations and unprecedented access within Clario's innovative platform.

Key Points: 
  • Clario and CellCarta's strategic partnership enhances clinical trial sample handling and digitization within Clario's web-based 21 CFR Part 11 compliant platform.
  • Together, Clario and CellCarta are set to make significant strides in improving clinical trial sample handling, ensuring seamless operations and unprecedented access within Clario's innovative platform.
  • CellCarta's clinical trial sample management offers kit provisioning and sample accessioning, processing, digitization, and quality control.
  • To explore the future of clinical trial sample management and learn more about Clario's transformative healthcare research technology, visit Clario.com .

Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster

Retrieved on: 
Monday, September 25, 2023
Research, Commercial Building & Real Estate, Medical Devices, Construction & Property, Health Technology, Biotechnology, General Health, Pharmaceutical, Health, Science, Partnership, CGT, Gene, QC, Multimedia, SOP, Cell, Quality control, United Kingdom, CRL, NYSE, Pharmaceutical industry, 3D printing, Stevenage

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of another RightSourceSM facility, and first in the United Kingdom, which will provide services to the Stevenage advanced therapies biocluster.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of another RightSourceSM facility, and first in the United Kingdom, which will provide services to the Stevenage advanced therapies biocluster.
  • RightSource is a flexible biologics testing lab , operated and managed by Charles River, making fast, reliable quality control (QC) more accessible to a broader reach of companies.
  • This platform-based QC lab will be operated by Charles River employees who will utilize Charles River’s quality management systems, test methods, and standard operating procedures (SOPs) to support QC testing needs.
  • Unlike standard insourcing solutions, RightSource offers clients the complete Charles River package of proprietary assays with all of the associated quality, scientific, and digital platforms.

ETQ Adds Lotus Clinical Research to Roster of Life Sciences Firms Finding Success with ETQ Reliance Quality Management System

Retrieved on: 
Tuesday, September 19, 2023
CAPA, Training management system, QMS, SOP, Risk, Lotus, Medical device, Hexagon

BURLINGTON, Mass., Sept.19, 2023 /PRNewswire/ -- ETQ, part of Hexagon, the leading quality management system (QMS) provider, is honored to have Lotus Clinical Research , a leading clinical research organization (CRO), join its roster of life sciences firms that are gaining advantage and reducing risk with ETQ's Reliance QMS serving as the foundational system for its enterprise-wide quality management program.

Key Points: 
  • BURLINGTON, Mass., Sept.19, 2023 /PRNewswire/ -- ETQ, part of Hexagon, the leading quality management system (QMS) provider, is honored to have Lotus Clinical Research , a leading clinical research organization (CRO), join its roster of life sciences firms that are gaining advantage and reducing risk with ETQ's Reliance QMS serving as the foundational system for its enterprise-wide quality management program.
  • "We're always pleased to see how our life sciences customers are able to adapt the ETQ Reliance platform to meet their specific needs, ensure compliance and help them automate core clinical processes, and Lotus Clinical Research stands out as a digital innovator," said David Isaacson, Vice President, Product Marketing ETQ.
  • Lotus is also using the Training Management application within Reliance to manage training requirements and ensure staff fully understand all SOPs.
  • "Thanks to our collaboration with ETQ, we have substantially enhanced the efficiency and effectiveness of our quality management organization.

ETQ Adds Lotus Clinical Research to Roster of Life Sciences Firms Finding Success with ETQ Reliance Quality Management System

Retrieved on: 
Tuesday, September 19, 2023
CAPA, Training management system, QMS, SOP, Risk, Lotus, Medical device, Hexagon

BURLINGTON, Mass., Sept.19, 2023 /PRNewswire/ -- ETQ, part of Hexagon, the leading quality management system (QMS) provider, is honored to have Lotus Clinical Research , a leading clinical research organization (CRO), join its roster of life sciences firms that are gaining advantage and reducing risk with ETQ's Reliance QMS serving as the foundational system for its enterprise-wide quality management program.

Key Points: 
  • BURLINGTON, Mass., Sept.19, 2023 /PRNewswire/ -- ETQ, part of Hexagon, the leading quality management system (QMS) provider, is honored to have Lotus Clinical Research , a leading clinical research organization (CRO), join its roster of life sciences firms that are gaining advantage and reducing risk with ETQ's Reliance QMS serving as the foundational system for its enterprise-wide quality management program.
  • "We're always pleased to see how our life sciences customers are able to adapt the ETQ Reliance platform to meet their specific needs, ensure compliance and help them automate core clinical processes, and Lotus Clinical Research stands out as a digital innovator," said David Isaacson, Vice President, Product Marketing ETQ.
  • Lotus is also using the Training Management application within Reliance to manage training requirements and ensure staff fully understand all SOPs.
  • "Thanks to our collaboration with ETQ, we have substantially enhanced the efficiency and effectiveness of our quality management organization.